Pulse Biosciences, Inc.

NasdaqCM:PLSE Stock Report

Market Cap: US$444.6m

Pulse Biosciences Dividend

Dividend criteria checks 0/6

Pulse Biosciences does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.76
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth

Dec 25
We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth

We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth

Sep 04
We Think Pulse Biosciences (NASDAQ:PLSE) Can Afford To Drive Business Growth

Pulse Biosciences (NASDAQ:PLSE) Has Debt But No Earnings; Should You Worry?

Mar 08
Pulse Biosciences (NASDAQ:PLSE) Has Debt But No Earnings; Should You Worry?

Pulse Biosciences appoints Kevin Danahy as CEO; Darrin Uecker to serve as CTO

Sep 20

Companies Like Pulse Biosciences (NASDAQ:PLSE) Could Be Quite Risky

Apr 04
Companies Like Pulse Biosciences (NASDAQ:PLSE) Could Be Quite Risky

Is Pulse Biosciences (NASDAQ:PLSE) Using Debt In A Risky Way?

Oct 29
Is Pulse Biosciences (NASDAQ:PLSE) Using Debt In A Risky Way?

Pulse Biosciences gets Health Canada approval for CellFX System

Jun 09

Is Pulse Biosciences (NASDAQ:PLSE) In A Good Position To Invest In Growth?

Mar 31
Is Pulse Biosciences (NASDAQ:PLSE) In A Good Position To Invest In Growth?

Who Has Been Buying Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares?

Feb 24
Who Has Been Buying Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares?

Pulse Biosciences establishes at-the-market equity program

Feb 04

What Percentage Of Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Do Insiders Own?

Jan 20
What Percentage Of Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Do Insiders Own?

Pulse Biosciences' CellFX System U.S. application moves forward for general dermatology indication

Jan 12

We're Keeping An Eye On Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate

Dec 16
We're Keeping An Eye On Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PLSE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PLSE's dividend payments have been increasing.


Dividend Yield vs Market

Pulse Biosciences Dividend Yield vs Market
How does PLSE dividend yield compare to the market?
SegmentDividend Yield
Company (PLSE)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Medical Equipment)1.8%
Analyst forecast in 3 Years (PLSE)n/a

Notable Dividend: Unable to evaluate PLSE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PLSE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PLSE's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PLSE has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.